IP Library Granted Patent US 8,821,861
Granted Patent B2
US 8,821,861 · App. 12/680,947 · Granted Sep 2, 2014

Fibrin sealant

Inventors: Stephanie A. Smith (Champaign, IL); James H. Morrissey (Champaign, IL)
Assignee: The Board of Trustees of the University of Illinois
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,821,861
App. No.
12/680,947
Granted
Sep 2, 2014
Kind
B2
Abstract

A fibrin sealant, comprises (a) thrombin, (b) fibrinogen, (c) polyP, and (d) calcium. The thrombin and the fibrinogen are separated prior to application.

Claims (25)

1. A fibrin sealant composition, comprising:

(a) a first container containing a first composition comprising isolated or recombinant thrombin, and

(b) a second container containing a second composition comprising: purified or recombinant fibrinogen, polyphosphate (polyPn), wherein n is at least 25, and calcium.

2. The fibrin sealant composition of claim 1 , wherein n is 25-1000.

3. The fibrin sealant composition of claim 1 , further comprising a cross-linking agent.

4. The fibrin sealant composition of claim 3 , wherein the cross-linking agent is factor XIII.

5. The fibrin sealant composition of claim 1 , further comprising a fibrinolysis inhibitor.

6. The fibrin sealant composition of claim 1 , wherein the fibrinogen is present in an amount between 2.5 to 200 mg/mL.

7. A fibrin sealant kit, comprising:

(I) a first container containing a first composition comprising isolated or recombinant thrombin,

(II) a second container containing a second composition, stored separate from the first composition, comprising: purified or recombinant fibrinogen, polyphosphate (polyPn), wherein n is at least 25, and calcium, and

(III) a fibrin sealant applicator.

8. The fibrin sealant kit of claim 7 , wherein n is 25-1000.

9. The fibrin sealant kit of claim 7 , further comprising a cross-linking agent.

10. The fibrin sealant kit of claim 9 , wherein the cross-linking agent is factor XIII.

11. The fibrin sealant kit of claim 7 , further comprising a fibrinolysis inhibitor.

12. The fibrin sealant kit of claim 7 , wherein the fibrin sealant applicator is a double barreled syringe.

13. The fibrin sealant kit of claim 7 , wherein the fibrin sealant applicator is a spray applicator.

14. The fibrin sealant composition of claim 1 , wherein the fibrinogen is recombinant fibrinogen.

15. The fibrin sealant composition of claim 1 , wherein the first composition and second composition are liquid.

16. The fibrin sealant composition of claim 1 , wherein the fibrinogen, polyPn and calcium have been incubated for at least 15 minutes.

17. The fibrin sealant kit of claim 7 , wherein the fibrinogen is recombinant fibrinogen.

18. The fibrin sealant kit of claim 7 , wherein the first composition and second composition are liquid.

19. The fibrin sealant kit of claim 7 , wherein the fibrinogen, polyPn and calcium have been incubated for at least 15 minutes.

20. The fibrin sealant kit of claim 7 , wherein the fibrinogen is present in an amount between 2.5 to 200 mg/mL.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2010
From: SMITH, STEPHANIE A.; MORRISSEY, JAMES H.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 024589/0945 →
CONFIRMATORY LICENSE Recorded Jun 3, 2010
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024480/0094 →
Continuity (2)
Provisional Application 60978009 · Oct 5, 2007
Related Publication 20100284998A1 · Nov 11, 2010